KC

Kamlesh Chandulal Shah

Active Director Director DIN 08850489
DIN 08850489 First appointment Aug 2020 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2020
Shareholding value •••• Premium profile

About Kamlesh Chandulal Shah

Data last updated:

Kamlesh Chandulal Shah is a Director at Tnine Pharmaceuticals Private Limited (since 2020). The company operates in Trading. Tnine Pharmaceuticals Private Limited reported revenue of ₹11.8 Lakh (FY 2025).

DIN 08850489
Primary Designation Director
Industry Trading
First Appointment 26 Aug 2020
Oldest Company Age 6 yrs
Largest company Tnine Pharmaceuticals Private Limited · ₹11.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Aug 20202020₹11.8 Lakh (FY 2025)Active

Board colleagues of Kamlesh Chandulal Shah

NameDINCompanyDesignation
Basundhara Singh08850490Tnine Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Tnine Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Kamlesh Chandulal Shah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kamlesh Chandulal Shah

Kamlesh Chandulal Shah currently holds 1 directorship: Tnine Pharmaceuticals Private Limited (Director, since 26 Aug 2020, revenue ₹11.8 Lakh (FY 2025)).

Kamlesh Chandulal Shah was first appointed on 26 Aug 2020 as Director at Tnine Pharmaceuticals Private Limited.

The current boards of Kamlesh Chandulal Shah's companies include Basundhara Singh (Tnine Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available